drugs from book Flashcards
categories of inotropic drugs & how they work
cardiac glycosides
sympatheomimetic amines
PDE3 inhibitors
all enhance cardiac contraction by increasing intracellular calcium concentration
shift frank-starling curveupward - so fof given Ven filling pressure –> SV & CO increased
two desired effects of digitoxin
1) improve contractility of failing heart
2) prolong refractorey period of the AV node in pts with SV arrhythmias
MOA of digoxin/digitalis
1) mechanical effect:
inhibition of sarcolemmmal Na/K aTPase pump
increase intracellular Na –> decreases amount of Ca extruded via Na/Ca exchanger–> so more Ca is pumped into SR
-subsequent AP more ca is released –> enhances force of contraction
2) electrical effect –> slows conduction velocity & increases refractoriness at AV node
modifies autonomic nervous system by enhancing vagal tone and reducing sympathetic activity
dangers of digitoxin
1) less negative resting potential –> bc inhibition of N/K atpase –> partial inactivation of fast Na channels - slower rise of phase 0 depolarization & reduction in conduction velocity –> can increase risk for reentrant arrhthmias
2) decreased action potential duration –> at high concentrations of dig –> elevated intracellular calcium increased acitvity of CA dependent K_ channel –> opening of thi schannel promotes K+ efflux and more rapid repolarization (also higher intracel Ca inactivates that Ca channels decreasing inward depolarizing curent) –> descrease in AP duration and associated shoretened refractory period increase the time during which cardiac fibers are responsive to external stimulation –> opportunity for propogation of arrhythmic impulses
3) enhanced automaticity –> less neg resting potential (may induce phase 4 depolairzation in nonpacemaker cells) & dig induced increase in Ca may trigger delayed afterpolarizations
clinical uses of digoxin
1) historically used to tx HF caused by decreased vent contracility ** only useful in HF if contactility failing
now usef in pts with HF complicated by afib or when symptoms don’t respond to acei, bb and diuretics
*does not prolong life expectancy of pts with CHF but improves QOL
2) antiarrhythmic agent in afib, a flutter and PSVT
(less common bc BB, CCB and amiodarone are more effective)
risk factors for dig toxicity
–> further inibits pump
hypomagnesemia
hypercalcemia
sympathomimetic amines MOA
bind cardiac Beta1 receptors –> increase acitivty of adenyalte cyclase, –> increased formation of cAMP
-increase cAMP activates protein kinases which promote intracellular Ca influx by phosphorylating L-type calcium channels –> increase calcium tentry triggers corresponding increase in Ca release from SR –> enhances force of contraction
names of sympathomimetic amines
dopamine & dobutamine –> used for acute HF (IV)
norepinephrine, epineprhine & isoproterenol
dopamine - clincial uses
precursor to norepi
1) low doses–> dopaminegic receptors in renal and mesenteric vascular beds –> local vasodilation & increases renal blood flow and glomerular filtarion, facilitating diuresis
2) medium doses –> increase inotropy by stimulating B1 receptors directly and indirectly promoting release of norepi from sympathetic nerve terminals
3) high doses –> dopa also stimulates alpha receptors –> vasocontriction and elevating systemic resistance –> high dose dopa in hypotensive states such as shock
loses efficacy after one week bc downregulation of receptors
dobutamine
synthetic dopamine that stimulats B1,2 &alpha
increase cardiac contractility (b1) but does nto increae peripheral vascular reistance bc balance bw alpha mediated vasocon and b2 mediated vasodil
useful in tx of HF not accompanied by hypotension
loses efficacy after one week bc downregulation of receptors
norepinephrine
B1 and alpha activity
B1 –> +inotropinc and chronotropic effects
potent vasocon
useful in pts with warm shock –> bc they have cardiac contactile dysfx and peripheral vasodilation (low BP)
epinephrine
alpha, b1 & b2
IV in low doses –> mostly b1 –> increases vent contractilty and speeds impulse generation & b2 –> vasodil reduct TPV and BP
higher doses –> potent vasopressor bc alpha action dominates b2
used most often in cadiac arrest –> combo of inotropic and chronotropic and vasoconstriction also helps in this setting
**not used w beta blockers –> bc unopposed alpha activity –> raise arterial bp
isoproterenol
synthetic epi but PURE beta - beta 1 & 2
+ inotropic and chronotropic effects –> increases CO
peripheral vasodilation –> reduction in peripheral resistance
used in emergenceis to increase heart rate in pts with brady or heart block
*not used in pts with my ocardial ischemia
milrinone
PDE 3 inhibitor –> inotropic agent
inhibition reduces breakdown of cAMP –> leads to enhanced Ca entry into cell and increaed contraction
in VSM –> increase cAMP results in vasodilation (b/c cAP inhibits myosin light chain kinases)
used to tx acute heart failyre when conventional vasocilators, inotropic agents and diuretics havent worked
potential for serious SE–> only used in hospital in ST
vasopressin
natural vasodilator that regulates water
at higher-than-natural doses potent vasoconstrictor bc directly stimulates vascular smooth muscle –> maintains BP for patients in vasodilatory shock
why is vasoconstriction initally helpful in HF?
maximaizes LV preload (increases venous tone enhances venous return) and helps to maintain systemic BP (bc of arterial constriction)
vasodilator drugs (names)
venodilators –> nitrates
mixed –> nitroprusside, aci, arbs, alpha blockers alpha 2 central agonist, nesiritide
arteriolar dilators–> hydralaizine, minoxidil, ccb
effects of acei
decreases systemic arterial pressue, facilitate natriursis, reduce adverse ventricular remodeling
increase BK (bc ace normally breaksdown) –> contributes to antihypertensive effect by stimulating release of NO
clincal uses of acei
1) htn –> descrease BP with little change in CO or HR (similar effect to BB & diuretics WITHOUT adversely affecting serum glucose or lipic concentrations so used in diabetic htn bc may slow diabetic nephropathy development
2) HF–> reduces afterload (PVR), reduce cardiac filling pressure (preload) and increase CO (BP unchanged due to balance) –> augmented CO lowers sympathetic stimulation –> so less norepi
improve survival in CHF and following MI
arbs
1)compete with angII at AT1 receptors –> more complete block of angII than acei bc alternative pathways
but do not affect BK levels
as effective as acei and are better tolerated
as with acei - htn effect is enhance with concurrent use of thiazide diuretic
2) severt HF - hemodynamic effects similar to acei (used in hf for pts intolerant of acei)
direct acting vasodilators - names
hydralazine
minoxidil
soidum nitroprusside
fenoldopam
first two used as LT oral agents
seoncd two IV in acute setting
hydralazine
potent and direct arteriolar dilator that acts on precapillary arterioles & no effect on systemic veins
MOA-unknown
fall in BP–> sympathetic activation –> tachy so often given with bblocker
not used often for htn
used to tx hf in pts with systolic dysfx with venodilatoer dinitrate –> improves symtpoms in pts with mild to moderate hf
**acetylated for excretion in liver –> varying degree of acetlyators!
SE- headache, palpitations, flushing, nauseua, anorexia
minoxidil
arteriolar vasodilatorion without venous impact
increase K channel permeability –> smooth muscle hyperpolarization and relaxation
often coadministered with BB
used for severe or intractable htn
SE-fluid retention & hypertrichosis
soidum nitroprusside
potent dilator of arteries and veins
IV for hypertensive emergencies & for preload and afterload modulation in severe CHF
metabolized by rbc –> liberates NO–> activates guanylate cyclase in VSM
Bblocker concurrently
onset within 30 seconds & peak with in 2 minutes
metabolized into cyanide –> liver transofrms into thiocyanate (levels msut be monitored)
effect of CCB in VSM
contraction of VSM depends on cytoplasmic ca concentration –> CCBs promote relaxation of VSM by inhibiting Ca entry thorugh voltage gated channels
effect of CCB in cardiac muscle
interfere with excitation contraction coupling and decrease force of contraction
also will slow rate of SA and AV firing if binds to open channel (verapamil & diltiazem)
CCB clinical uses
1) angina pectoris –> decrease myocardial o2 comsumption & increae supply (dilation)
2) coronary artery spams –> vasodilate
3) htn –> arterial smooth muscle relazation
4) SV arrthymias –> decrease conduction velocity & increase refrcatoriness of AV node
**often used in htn –> more than bb and aci espeically in elderly pts